Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

Supplementation with cholecalciferol 1000 IU/day during pregnancy is associated with greater offspring bone mineral density during childhood.

Amgen said on Wednesday it does not see any bone safety concerns around the use of its experimental obesity drug, a day after ...

Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Research indicates that vitamin D supplementation during pregnancy positively impacts children's bone health and lean mass, ...

Patients with cystic fibrosis (CF) experience significant bone mineral density (BMD) loss at a younger age than those without the disease, with greater decline observed among individuals with ...

Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data ...

Muskoka Algonquin Healthcare and Huntsville Hospital Foundation are pleased to unveil a new, state-of-the-art Bone Mineral ...

Investigators used 3-dimensional quantitative computed tomography to more accurately assess patients’ bone mineral density.

Shares of Amgen fell as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss ...

Lung transplant patients should undergo annual bone health screenings using dual-energy X-ray absorptiometry for the first ...

Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone ...